Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1081)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$519.17
Total Value
$41.53K
Shares Held After
332,695
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$517.83
Total Value
$41.43K
Shares Held After
332,775
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$516.73
Total Value
$62.01K
Shares Held After
332,855
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
263
Price
$516.21
Total Value
$135.76K
Shares Held After
332,975
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$514.92
Total Value
$321.83K
Shares Held After
333,238
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$512.50
Total Value
$41.00K
Shares Held After
333,863
% of Holdings
0.0%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
18,278
Price
$129.40
Total Value
$2.37M
Shares Held After
60,486
% of Holdings
23.2%
INSMED Inc (INSM)
Flammer Martina M.D. — Chief Medical Officer
Shares
8,895
Price
$127.00
Total Value
$1.13M
Shares Held After
78,764
% of Holdings
10.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
320
Price
$522.39
Total Value
$167.17K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,308
Price
$521.50
Total Value
$682.12K
Shares Held After
45,492
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
360
Price
$518.82
Total Value
$186.78K
Shares Held After
46,800
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
780
Price
$517.94
Total Value
$403.99K
Shares Held After
47,160
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,617
Price
$516.93
Total Value
$835.87K
Shares Held After
47,940
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,360
Price
$515.93
Total Value
$701.67K
Shares Held After
49,557
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,795
Price
$514.82
Total Value
$924.11K
Shares Held After
50,917
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
760
Price
$512.92
Total Value
$389.82K
Shares Held After
52,712
% of Holdings
1.4%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
5,500
Price
$134.17
Total Value
$737.93K
Shares Held After
168,498
% of Holdings
3.2%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
45,004
Price
$212.01
Total Value
$9.54M
Shares Held After
7,229
% of Holdings
86.2%
ACADIA PHARMACEUTICALS INC (ACAD)
Schneyer Mark C. — EVP, CHIEF FINANCIAL OFFICER
Shares
5,849
Price
$29.00
Total Value
$169.64K
Shares Held After
67,828
% of Holdings
7.9%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
187,044
Price
$58.79
Total Value
$11.00M
Shares Held After
6,187,791
% of Holdings
2.9%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
39,891
Price
$58.12
Total Value
$2.32M
Shares Held After
6,374,835
% of Holdings
0.6%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
124,838
Price
$56.96
Total Value
$7.11M
Shares Held After
6,414,726
% of Holdings
1.9%
Moderna, Inc. (MRNA)
Bancel Stephane — Director
Shares
147,473
Price
$56.21
Total Value
$8.29M
Shares Held After
6,539,564
% of Holdings
2.2%
INCYTE CORP (INCY)
Mayes Patrick A — EVP&Chief Scientific Officer
Shares
2,207
Price
$123.99
Total Value
$273.65K
Shares Held After
61,441
% of Holdings
3.5%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
10,640
Price
$122.69
Total Value
$1.31M
Shares Held After
204,804
% of Holdings
4.9%
ProMIS Neurosciences Inc. (PMN)
Kaplan Johanne — Chief Development Officer
Shares
2,280
Price
$13.30
Total Value
$30.32K
Shares Held After
6,221
% of Holdings
36.7%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
5,000
Price
$0.26
Total Value
$1.29K
Shares Held After
31,294
% of Holdings
16.0%
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
279
Price
$3.65
Total Value
$1.02K
Shares Held After
68,245
% of Holdings
0.4%
Cocrystal Pharma, Inc. (COCP)
FROST PHILLIP MD ET AL — Director
Shares
10,000
Price
$0.98
Total Value
$9.82K
Shares Held After
1,993,551
% of Holdings
0.5%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
50,417
Price
$19.28
Total Value
$972.04K
Shares Held After
316,797
% of Holdings
13.7%
Fortrea Holdings Inc. (FTRE)
Thakral Anshul — Director
Shares
49,452
Price
$19.03
Total Value
$941.07K
Shares Held After
367,214
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$524.59
Total Value
$83.93K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
261
Price
$523.88
Total Value
$136.73K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
939
Price
$522.66
Total Value
$490.78K
Shares Held After
324,864
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,385
Price
$521.64
Total Value
$722.48K
Shares Held After
325,803
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,011
Price
$520.58
Total Value
$526.30K
Shares Held After
327,188
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,496
Price
$519.62
Total Value
$777.35K
Shares Held After
328,199
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,891
Price
$518.51
Total Value
$980.50K
Shares Held After
329,695
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
557
Price
$517.48
Total Value
$288.24K
Shares Held After
331,586
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
386
Price
$516.72
Total Value
$199.46K
Shares Held After
332,143
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
205
Price
$515.44
Total Value
$105.67K
Shares Held After
332,529
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
529
Price
$514.28
Total Value
$272.05K
Shares Held After
332,734
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$511.07
Total Value
$40.89K
Shares Held After
333,263
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$510.28
Total Value
$81.64K
Shares Held After
333,343
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$507.24
Total Value
$81.16K
Shares Held After
333,503
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$504.31
Total Value
$40.34K
Shares Held After
333,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$502.29
Total Value
$100.46K
Shares Held After
333,743
% of Holdings
0.1%
Tiziana Life Sciences Ltd (TLSA)
Elrifi Ivor — Chief Executive Officer
Shares
237,616
Price
$1.00
Total Value
$237.62K
Shares Held After
4,793,684
% of Holdings
5.0%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
4,356
Price
$25.00
Total Value
$108.90K
Shares Held After
117,227
% of Holdings
3.6%
Vaxcyte, Inc. (PCVX)
Dhaliwal Harpreet S. — Chief Technical Ops Officer
Shares
17,000
Price
$55.00
Total Value
$935.07K
Shares Held After
76,756
% of Holdings
18.1%
Showing 301–350 of 1081 transactions (page 7 of 22)